CheckMyRecalls

10,013 recalls · updated 20 Nov 2026

The Harvard Drug Group LLC recalls Carton Label

Read the official FDA notice

Published
1 Jul 2026
Units affected
790 Cartons.
Agency
FDA
Country
United States

The hazard

Subpotent Drug

Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What to do

Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.

  • Check the lot number on the box or bottle.
  • Talk to your pharmacist or doctor before stopping any prescribed medicine.
  • Return the product to the pharmacy for safe disposal.
Read the official FDA notice

Product details

Carton Label: MAJOR, Methylergonovine Maleate Tablets, USP, 0.2 mg, 20 TABLETS (2 x 10), Rx only, Packaged and Distributed by: MAJOR PHARMACEUTICALS, Indianapolis, in 46268, NDC 0904-7282-10. Blister Label: Methylergonovine Maleate Tablets, 0.2 mg, USP, One Tablet, Major Pharm/Indianapolis, IN 46268, NDC 0904-7282-10.

Brand / company
The Harvard Drug Group LLC
Codes / lots
Lots: N02327, expires: 09/2026; N02740, expires: 12/2026; N03069, expires: 08/2027.
Distribution
U.S. Nationwide.
Recall status
Ongoing

Source: U.S. Food and Drug Administration, published 1 Jul 2026. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.